GlassScriptPhysician profile
Jeffrey C Brittan
NPI 1578591103
$4,087.43
in general payments reported to CMS, 2019-2025
39 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $545 · 2021: $739 · 2022: $711 · 2023: $743 · 2024: $590 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $469.04 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $406.26 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Novo Nordisk INC | $371.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $318.12 | 2019-2024 | Otezla, Repatha, Prolia |
| Pfizer INC. | $315.16 | 2019-2025 | |
| Abbvie INC. | $249.94 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $189.05 | 2019-2022 | |
| Astellas Pharma US INC | $184.55 | 2019-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $183.53 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $149.65 | 2020-2023 | |
| Exact Sciences Corporation | $132.90 | 2023-2024 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $88.51 | 2020-2025 | Eliquis |
| Daiichi Sankyo INC. | $88.02 | 2021 | |
| Merck Sharp & Dohme LLC | $86.45 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Astrazeneca Pharmaceuticals LP | $84.41 | 2020-2025 | Breztri, Airsupra |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brittan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.